Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine GON blockade in chronic migraine
NCT02188394Phase 2Completed
- Start
- Jul 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine in chronic migraine. Started Jul 2014; status: completed.
02
Drugs
bupivacaine
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT02188394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02188394.